Biocon Ltd
NSE:BIOCON

Watchlist Manager
Biocon Ltd Logo
Biocon Ltd
NSE:BIOCON
Watchlist
Price: 315.5 INR 2.45% Market Closed
Updated: May 23, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

11.7B
-37%
Operating Cash Flow
Growth Rates:
1 Year
+2%
3 Years
+14%
5 Years
+731%
7 Years
-
10 Years
-
-136B
+5%
Investing Cash Flow
Growth Rates:
1 Year
-408%
3 Years
-647%
5 Years
-34 338%
7 Years
-
10 Years
-
121.1B
-7%
Financing Cash Flow
Growth Rates:
1 Year
+641%
3 Years
+958%
5 Years
-
7 Years
-
10 Years
-

Cash Flow Statement
Biocon Ltd

Rotate your device to view
Cash Flow Statement
Currency: INR
Jun-2004 Sep-2004 Dec-2004 Mar-2005 Jun-2005 Sep-2005 Dec-2005 Mar-2006 Jun-2006 Mar-2007 Sep-2007 Mar-2008 Sep-2018 Mar-2019 Sep-2019 Mar-2020 Sep-2020 Mar-2021 Sep-2021 Mar-2022 Sep-2022 Mar-2023 Sep-2023
Operating Cash Flow
Net Income
2 137
1 953
2 134
2 151
2 081
2 004
1 961
2 030
2 000
2 110
2 780
5 387
5 160
10 026
9 681
8 709
7 612
8 559
7 522
7 716
7 527
6 430
7 154
Depreciation & Amortization
210
180
204
223
247
270
283
300
340
665
1 015
939
2 113
4 478
4 923
5 522
6 409
7 151
7 669
8 142
8 662
11 131
14 121
Other Non-Cash Items
3
(45)
0
(125)
0
0
0
0
0
978
0
0
(899)
248
3 507
3 692
2 991
2 063
3 249
6 423
7 442
8 260
8 173
Cash Taxes Paid
208
162
107
120
129
171
220
230
250
132
142
243
1 065
2 915
3 021
3 441
3 106
1 938
2 139
2 620
2 578
2 286
2 387
Cash Interest Paid
45
31
0
41
0
0
0
0
0
101
0
104
521
1 007
820
912
996
1 160
1 347
1 096
1 300
4 856
7 913
Change in Working Capital
(771)
(484)
(591)
(554)
(332)
(258)
(764)
(1 520)
(1 450)
(2 206)
(2 226)
(3 148)
(4 964)
(3 206)
(3 538)
(5 092)
(6 749)
(6 514)
(5 456)
(10 177)
(12 088)
(7 296)
(17 731)
Cash from Operating Activities
1 577
N/A
1 603
+2%
1 732
+8%
1 729
0%
1 918
+11%
1 958
+2%
1 389
-29%
810
-42%
890
+10%
1 548
+74%
2 548
+65%
3 178
+25%
1 410
-56%
11 546
+719%
14 573
+26%
12 831
-12%
10 263
-20%
11 259
+10%
12 984
+15%
12 104
-7%
11 543
-5%
18 525
+60%
11 717
-37%
Investing Cash Flow
Capital Expenditures
(1 307)
(1 740)
(2 278)
(2 850)
(3 291)
(3 303)
(3 240)
(2 290)
(2 100)
(1 906)
(2 436)
(2 325)
(5 746)
(14 920)
(17 989)
(18 365)
(17 060)
(17 463)
(19 129)
(19 248)
(18 379)
(17 263)
(17 958)
Other Items
(3 485)
(3 182)
(2 725)
(2 002)
2 160
2 303
2 228
1 430
480
(6)
214
(1 076)
5 351
7 782
4 379
2 776
(1 153)
(18 784)
(14 579)
2 257
(8 396)
(125 555)
(118 073)
Cash from Investing Activities
(4 792)
N/A
(4 923)
-3%
(5 003)
-2%
(4 852)
+3%
(1 131)
+77%
(999)
+12%
(1 012)
-1%
(860)
+15%
(1 620)
-88%
(1 912)
-18%
(2 222)
-16%
(3 401)
-53%
(395)
+88%
(7 138)
-1 707%
(13 610)
-91%
(15 589)
-15%
(18 213)
-17%
(36 247)
-99%
(33 708)
+7%
(16 991)
+50%
(26 775)
-58%
(142 818)
-433%
(136 031)
+5%
Financing Cash Flow
Net Issuance of Common Stock
3 150
3 150
3 150
0
0
0
0
0
0
0
0
0
1
(692)
(779)
5 388
7 974
7 977
5 763
425
(337)
12 016
12 744
Net Issuance of Debt
164
266
277
20
0
0
0
0
0
817
0
687
515
75
2 316
126
4 471
18 823
12 446
3 092
6 533
124 045
130 399
Cash Paid for Dividends
0
0
0
(100)
0
0
0
0
0
(250)
0
(300)
(793)
(793)
(702)
(701)
1
0
0
0
(719)
(718)
(2 029)
Other
(105)
(100)
0
94
(379)
(578)
(48)
50
710
(136)
(836)
(155)
(521)
(1 007)
(832)
(937)
(1 009)
(1 160)
(1 347)
(1 096)
10 850
(4 856)
(20 063)
Cash from Financing Activities
3 208
N/A
3 314
+3%
3 274
-1%
(18)
N/A
(743)
-4 028%
(946)
-27%
(398)
+58%
50
N/A
710
+1 320%
431
-39%
(269)
N/A
232
N/A
(798)
N/A
(2 417)
-203%
3
N/A
3 876
+129 100%
11 437
+195%
25 640
+124%
16 862
-34%
2 421
-86%
16 327
+574%
130 487
+699%
121 051
-7%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
0
0
204
112
(13)
536
316
71
233
33
237
217
(107)
Net Change in Cash
(7)
N/A
(6)
+14%
3
N/A
(3 141)
N/A
44
N/A
13
-70%
(21)
N/A
0
N/A
(20)
N/A
67
N/A
57
-15%
9
-84%
421
+4 578%
2 103
+400%
953
-55%
1 654
+74%
3 803
+130%
723
-81%
(3 629)
N/A
(2 433)
+33%
1 332
N/A
6 411
+381%
(3 370)
N/A
Free Cash Flow
Free Cash Flow
270
N/A
(137)
N/A
(546)
-299%
(1 121)
-105%
(1 373)
-22%
(1 345)
+2%
(1 851)
-38%
(1 480)
+20%
(1 210)
+18%
(358)
+70%
112
N/A
853
+662%
(4 336)
N/A
(3 374)
+22%
(3 416)
-1%
(5 534)
-62%
(6 797)
-23%
(6 204)
+9%
(6 145)
+1%
(7 144)
-16%
(6 836)
+4%
1 262
N/A
(6 241)
N/A

See Also

Summary
BIOCON intrinsic value, competitors valuation, and company profile.
DCF Valuation
BIOCON stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BIOCON stock valuation using valuation multiples.
Wall Street Estimates
BIOCON price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BIOCON stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 140,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.